Figure 2: Circulating ALDH

(A–C) The frequency of circulating ALDHhiSSClow progenitor cells with primitive cell phenotype (CD34+CD133+) was reduced in patients with T2D compared with control subjects. (D–F) The frequency of circulating ALDHhiSSClow progenitor cells with early myeloid cell phenotype (CD34+CD33+) was reduced in patients with T2D compared with control subjects. (G–I) The frequency of circulating ALDHhiSSClow progenitor cells with migratory phenotype (CD34+CXCR4+) was reduced in patients with T2D compared with control subjects. Values are mean ± SEM. ***p < 0.01 with the Student's t-test. Abbreviations as in Figure 1.